FDA
approval
· 2013-10-25
FDA Approved: VIZAMYL — Original Application (GE Healthcare Inc. (Medi-Physics, Inc. dba GE Healthcare))
Summary
FDA approved Vizamyl (flutemetamol F-18) under an original application as a PET imaging agent to detect beta-amyloid plaques in adult patients being evaluated f…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for VIZAMYL (FLUTEMETAMOL F-18)